The skin shows an important "epidermal permeability barrier homeostasis" in response to barrier disruption. Calcium ion (Ca 2+ ), a major regulator in keratinocyte diVerentiation and proliferation, plays a crucial role in skin barrier homeostasis. Acute barrier disruption induces an immediate depletion of both extra-and intracellular calcium ions in the epidermis, especially in the upper granular layers, and results in the loss of normal epidermal calcium gradient. Currently, we hypothesize that the change in the intracellular calcium ion concentration triggers the barrier repair responses, such as lamellar body (LB) secretion and increased lipid synthesis in the epidermis. In this article, we suggest that PKC-delta is a signaling mediator for the changes in extracellular and intracellular calcium ion concentration.
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Homeostasis is a fundamental process by which living organisms stably maintain their internal conditions against external environmental changes. To maintain homeostasis, our bodies conduct multiple dynamic equilibrium adjustments, tightly controlled by closely interrelated regulatory mechanisms. Most of the homeostatic systems working in our body are comprised of three components: receptors, signal transducers and eVectors (Fig. 1a) . The Wrst components, receptors, sense and report changes in the external environment. The second components, signal transducers, convert and magnify the receptor's signals into another transducer and/or eVector. This process, referred to as 'signal transduction', generally involves a sequence of biochemical reactions inside the cell, which are carried out by enzymes or linked through second messengers. The last one is the eVectors, which show the 'responses' by eliciting the appropriate cellular changes in response to the environmental changes. Most viable organs have homeostatic control systems. For example, the pancreas produces insulin and glucagon to control blood-sugar concentration. The lungs take in oxygen and give oV carbon dioxide. The kidneys remove urea, and adjust the concentrations of water and a wide variety of ions.
The skin is the largest and the outermost organ of the human body. Skin controls transcutaneous water movement, protects the internal organs form mechanical insults, and defends the human body from pathogenic microbes, UV-irradiation and free radicals. Of course, the skin also has homeostatic control system; so called 'barrier repair response' (Fig. 1b) . When the barrier is compromised by either external insult or abnormal nutritional supplement, such as seen in the essential fatty acid deWciency (EFAD) model, the homeostatic response includes increasing lamellar body (LB) secretion and epidermal lipid synthesis [18] .
The initiation of the epidermal barrier repair response depends on a certain signal and several signals have been suggested as possible candidates. Firstly, increased transepidermal water loss (TEWL) and subsequent changes in osmotic pressure of epidermal keratinocyte were suggested as regulatory signals for barrier homeostasis. A series of experiments using animal models, however, showed that, when the barrier-perturbed skin was immersed in aqueous solution, the tonicity of the solution did not aVect the barrier recovery rate, which suggests that the change of tonicity is not a primary signal for barrier homeostasis [15] . Increased secretion and synthesis of epidermal cytokines, subsequent to barrier abrogation, was also observed in both human and murine skin [31] . The cytokines are one of the most characterized classes of signaling molecules and they regulate downstream processes of barrier homeostasis, such as keratinocyte proliferation and lipid synthesis [9] . However, the blockade of permeability barrier recovery using a water vapor impermeable membrane did not prevent the change of epidermal cytokine expression, suggesting that the cytokines are not primary signaling molecules for barrier homeostasis. Ca 2+ acts as a major regulator in keratinocyte diVerentiation and proliferation and is thought to be a main signal transducer for skin barrier homeostasis. The concentration gradient of Ca 2+ within the epidermis, with its highest levels in the stratum granulosum (SG) and lowest levels in the basal cell layer [23] , is important for both permeability barrier homeostasis and epidermal diVerentiation. Barrier disruption causes an immediate depletion of both intracellular and extracellular calcium ions in the SG, resulting in the loss of the normal epidermal calcium gradient [20, 22, 24] . Previously, Mauro et al. [22] showed that the peak Ca 2+ concentrations within the outer epidermis fell from 460 § 57 mg per kg to 128 § 14 mg per kg immediately after barrier disruption. Along with the permeability barrier recovery, the calcium ion concentration in the SG also increased and immersion of the barrier-perturbed skin into a calcium ion-containing solution delayed barrier recovery, suggesting a role for calcium ions in epidermal permeability barrier homeostasis. The crucial role of Ca 2+ in barrier homeostasis was also shown by the observation that LB secretion can be manipulated by changes in Ca 2+ by iontophoresis and sonophoresis, independent of barrier abrogation. These studies suggest that changes of epidermal calcium can be an important signal transducer for barrier repair in vivo, independent of changes in barrier function [17] .
However, most of the above studies mention the role of calcium ions in cutaneous barrier functions as extracellular calcium gradient or intracellular free calcium level ([Ca   2+ ] i ), separately. While the decrease of extracellular calcium ion concentration after barrier disruption can be explained by the passive outward calcium ion displacement induced by increased transcutaneous water loss, the exact mechanism underlying the decrease in [Ca 2+ ] i in response to lowered extracellular calcium ion concentration is still not clear.
There is a substantial and precisely controlled diVerence between intracellular free calcium ions and extracellular calcium ion concentration, and the extracellular free calcium level ( [21] . Several diVerent mechanisms are involved in regulating physiological [Ca 2+ ] i , such as plasma membrane Ca 2+ channels, plasma membrane calcium ATPase (PMCA), sarco-endoplasmic membrane calcium ATPase (SERCA), and Na+-H+ exchangers (NHEs). Calcium ions, localized intracellularly, are stored within organelles, usually the endoplasmic reticulum (sarcoplasmic reticulum in muscle cells), where it is bound to molecules like calreticulin. Due to the above mentioned mechanisms, the concentration of free Ca 2+ within the cell is usually very low. The mechanism of increased [Ca 2+ ] i in the upper SG layer in response to the elevation of extracellular calcium is understood by degrees [28] . Previous studies [2, 10, 30] suggested that the extracellular calcium-sensing receptor (CaR) is involved in mediating calcium signaling during keratinocyte diVerentiation. Activation of CaR with calcium or other multivalent cations activates the phospholipase C signaling pathway, resulting in the generation of inositol 1, 4, 5-trisphosphate, the release of calcium from intracellular stores [4, 14] and a subsequent increase in calcium inXux through nonspeciWc cation channels and a storage-operated calcium channel. This is followed by the activation of PKC [18] and elevated expression of diVerentiation-related genes such as loricrin, proWlaggrin, and transglutaminase [5] . During the diVerentiation process of keratinocytes, PKC activation not only precedes the expression of diVerentiation markers but also induces diVerentiation [5, 6, 8, 17] . And the speciWc PKC isotype, PKC , has been implicated in this process [5, 6, 16] .
We hypothesized that the decrease of [Ca 2+ ] i might be mediated by some signal transducers during the acute barrier disruption, just as the increase of [Ca 2+ ] i is mediated by receptors and signal transducers (such as CaR, phospholipase C and PKC) during terminal diVerentiation. Murata et al. demonstrated that both serine-palmitoyl transferase and glucosylceramide synthetase expression were increased through a PKCdependent mechanism in cultured human keratinocytes. 1 This result provides a hint that PKC may be a key candidate signal transducer for the decrease of [Ca 2+ ] i . So, we investigated the eVects of PKC inhibitors on the barrier recovery [1] . Our results show that both a broad-type PKC inhibitor and a speciWc PKC inhibitor reduced barrier recovery (Fig. 2) , speciWcally through the inhibition of the [Ca 2+ ] i decrease by PKC (especially PKC ) (Fig. 3 ). While both a broad-type PKC inhibitor and a speciWc PKC inhibitor showed the inhibitory eVect on the decrease of [Ca 2+ ] i after lowering [Ca 2+ ] o, as shown in Figs. 3b , c, the intracellular calcium responses to chelerythrine chloride (broadtype PKC inhibitor) is slightly diVerent from that of rottlerin (speciWc PKC inhibitor). The calcium trace of chelerythrine chloride-treated keratinocytes showed an unstable and increasing baseline. And when the extracellular calcium level was increased, the increase of calcium trace of chelerythrine chloride was slower than that of rottlerin. Because this type of calcium trace can be shown for unregulated calcium inXux such as with the cytotoxic eVect, we measured the cytotoxicity of chelerythrine chloride and rottlerin in cultured keratinocytes by the Alamar Blue ™ assay. This study showed less than ten percent cytotoxicity in the chelerythrine chloride-treated cell culture. But rottlerin didn't show any cytotoxicity at all. Although, the calcium trace of chelerythrine chloride showed an increasing baseline and slower increase, we think these features are secondary eVects due to weak cytotoxicity which masks the typical calcium curve as shown in Fig. 3c . Also, because chelerythrine chloride is a broadtype PKC inhibitor, its eVect could be the sum of other blocking eVects from other isoenzymes of PKC other than delta.
The role of PKC in keratinocyte diVerentiation is well known, but until now, nothing was known about its role in the barrier recovery response, especially with regards to the decrease of [Ca 2+ ] i . But, a similar regulation of [Ca 2+ ] i is seen in cells other than keratinocytes, namely granulosa cells. Basic Wbroblast growth factor Fig. 2 Broad-type PKC inhibitors and speciWc PKC inhibitor delay the barrier recovery. a Topical application of chelerythrine chloride, a broad-type PKC inhibitor, delayed the barrier recovery rate in a dose-dependent manner. b The percent recovery of TEWL in rottlerin-treated skin was also decreased in a dosedependent manner (**P < 0.01) prevents granulosa cell apoptosis by decreasing [Ca 2+ ] i [19] . Peluso et al. [25] elucidated the mechanism through which bFGF-activated PKC regulates [Ca 2+ ] i within a physiological range by stimulating calcium eZux. They proposed that activated PKC functions as a serine/threonine phosphorylator of various molecular targets that may include calcium eZux regulators, such as PMCA. As shown in other cell types, TPA-dependent phosphorylation of PMCA enhances the rate of calcium eZux, thereby maintaining calcium homeostasis [13] . The PMCA pumps are localized in the plasma membrane, and their activities are inXuenced by PKC [3, 26, 29] . But, PKC is the only PKC isotype that is expressed by granulosa cells. The existence of PKC , ,
, and in keratinocytes is well-documented [5, 7, 11, 17] and other PKC isoforms (namely PKC , , and ) were also found in various keratinocyte cell lines [11, 12, 27] . Among the normally existing PKC isoenzymes in keratinocytes, PKC is a novel isoform of PKC, and is DAG-sensitive but calcium-insensitive. These results suggest the role of PKC-as a signal mediator in epidermal permeability barrier homeostasis, especially in regulating intracellular calcium concentration. Our suggested mechanism of calcium regulation by PKC is shown in Fig. 4 . When the permeability barrier is disrupted, there is TEWL increase, followed by a decrease of the extracellular calcium level in the upper epidermis. The extracellular calcium loss is sensed and reported by an unknown receptor. This receptor may increase the level of DAG, an endogenous PKC activator, and activate PKC as a signal transducer. 
